We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
Cap. Flow
-$218M
Cap. Flow %
-2.1%
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$125M
2
PRGO icon
Perrigo
PRGO
+$103M
3
AGN
Allergan plc
AGN
+$99.6M
4
PFE icon
Pfizer
PFE
+$90M
5
VTRS icon
Viatris
VTRS
+$88.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.63%
2 Healthcare 15.57%
3 Communication Services 13.26%
4 Technology 11.56%
5 Financials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTB
151
DELISTED
Cooper Tire & Rubber Co.
CTB
$15.8M 0.15%
427,811
+366,517
+598% +$13.4M
KSU
152
DELISTED
Kansas City Southern
KSU
$15.8M 0.15%
184,372
+34,885
+23% +$2.72M
CSCO icon
153
Cisco
CSCO
$450B
$15.5M 0.15%
545,117
-231,507
-30% -$5.96M
MANH icon
154
Manhattan Associates
MANH
$8.97B
$15M 0.14%
264,118
+126,593
+92% +$7.04M
CME icon
155
CME Group
CME
$92.2B
$14.9M 0.14%
155,551
+128,427
+473% +$11.7M
LAZ icon
156
Lazard
LAZ
$4.37B
$14.7M 0.14%
379,211
-1,249,256
-77% -$44.8M
CPT icon
157
Camden Property Trust
CPT
$11.3B
$14.5M 0.14%
172,069
-130,704
-43% -$9.98M
INCY icon
158
Incyte
INCY
$23.5B
$14.3M 0.14%
196,786
+183,209
+1,349% +$13.7M
BECN
159
DELISTED
Beacon Roofing Supply, Inc.
BECN
$14.2M 0.14%
+345,396
New +$13.1M
TPR icon
160
Tapestry
TPR
$28.8B
$14M 0.14%
349,946
+76,814
+28% +$2.78M
LOGM
161
DELISTED
LogMein, Inc.
LOGM
$13.9M 0.13%
274,971
+105,452
+62% +$5.44M
TRU icon
162
TransUnion
TRU
$14.8B
$13.3M 0.13%
481,102
+435,817
+962% +$11.1M
WSM icon
163
Williams-Sonoma
WSM
$26.7B
$13.2M 0.13%
+481,346
New +$13.1M
CONE
164
DELISTED
CyrusOne Inc Common Stock
CONE
$13.1M 0.13%
+287,063
New +$11M
JPM icon
165
JPMorgan Chase
JPM
$939B
$13.1M 0.13%
220,956
+5,961
+3% +$348K
FDS icon
166
Factset
FDS
$9.05B
$13.1M 0.13%
86,291
+2,498
+3% +$373K
ATHN
167
DELISTED
Athenahealth, Inc.
ATHN
$13M 0.13%
93,792
+56,593
+152% +$7.76M
ALGN icon
168
Align Technology
ALGN
$12B
$13M 0.13%
+179,006
New +$11.7M
FCE.A
169
DELISTED
Forest City Realty Trust, Inc.
FCE.A
$13M 0.13%
+615,674
New +$12.1M
CDK
170
DELISTED
CDK Global, Inc.
CDK
$12.9M 0.12%
277,729
+230,033
+482% +$10.2M
PCTY icon
171
Paylocity
PCTY
$6.71B
$12.9M 0.12%
392,916
+9,919
+3% +$309K
FRGI
172
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$12.8M 0.12%
389,853
+178,603
+85% +$6.29M
TSCO icon
173
Tractor Supply
TSCO
$16.3B
$12.8M 0.12%
+705,315
New +$12.1M
WAB icon
174
Wabtec
WAB
$51.1B
$12.7M 0.12%
+160,108
New +$11.1M
VOYA icon
175
Voya Financial
VOYA
$8.94B
$12.7M 0.12%
425,840
+294,369
+224% +$8.91M

Similar funds

Marshall Wace's Q1 2016 Portfolio in Review

As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
  • Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
  • Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
  • Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
  • Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
  • Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.

Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.